Therapeutic targeting of autophagy in cancer. Part I: Molecular pathways controlling autophagy

Seminars in Cancer Biology

Volumn 31, Issue , 2015, Pages 89-98

  Nagelkerke, Anika ^a   Sweep, Fred C G J ^a   Geurts Moespot, Anneke ^a   Bussink, Johan ^a   Span, Paul N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autophagy; Cancer; Signalling pathways

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PKR LIKE ENDOPLASMIC RETICULUM KINASE; PROTEIN IRE1; PROTEIN KINASE R; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; WNT PROTEIN;

AUTOPHAGOSOME; CANCER CELL; CANCER INHIBITION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; HUMAN; INTRACELLULAR SIGNALING; MACROAUTOPHAGY; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE; ONCOGENE C MYC; REVIEW; TUMOR SUPPRESSOR GENE; UNFOLDED PROTEIN RESPONSE; WNT SIGNALING PATHWAY; AUTOPHAGY; BIOLOGICAL MODEL; HOMEOSTASIS; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AUTOPHAGY; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84923259951     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.05.004     Document Type: Review

References (139)

1. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330:1344-1348.
2. Mazure N.M., Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival. Curr Opin Cell Biol 2010, 22:177-180.
3. Rouschop K.M., Ramaekers C.H., Schaaf M.B., Keulers T.G., Savelkouls K.G., Lambin P., et al. Autophagy is required during cycling hypoxia to lower production of reactive oxygen species. Radiother Oncol 2009, 92:411-416.
4. Sato K., Tsuchihara K., Fujii S., Sugiyama M., Goya T., Atomi Y., et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 2007, 67:9677-9684.
5. Tang D., Kang R., Cheh C.W., Livesey K.M., Liang X., Schapiro N.E., et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310.
6. Tang D., Kang R., Livesey K.M., Cheh C.W., Farkas A., Loughran P., et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010, 190:881-892.
7. Kang R., Tang D., Lotze M.T., Zeh Iii H.J. Autophagy is required for IL-2-mediated fibroblast growth. Exp Cell Res 2013, 319:556-565.
8. Huang J., Ni J., Liu K., Yu Y., Xie M., Kang R., et al. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 2012, 72:230-238.
9. Obara K., Sekito T., Niimi K., Ohsumi Y. The Atg18-Atg2 complex is recruited to autophagic membranes via phosphatidylinositol 3-phosphate and exerts an essential function. J Biol Chem 2008, 283:23972-23980.
10. Rubinsztein D.C., Shpilka T., Elazar Z. Mechanisms of autophagosome biogenesis. Curr Biol 2012, 22:R29-R34.
11. Hamasaki M., Furuta N., Matsuda A., Nezu A., Yamamoto A., Fujita N., et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013, 495:389-393.
12. Eskelinen E.L., Tanaka Y., Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 2003, 13:137-145.
13. Li Y., Zhang Q., Tian R., Wang Q., Zhao J.J., Iglehart J.D., et al. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Cancer Res 2011, 71:7481-7489.
14. Nagelkerke A., Sieuwerts A.M., Bussink J., Sweep C.G., Look M.P., Foekens J.A., et al. LAMP3 is involved in tamoxifen resistance in breast cancer through modulation of autophagy. Endocr Relat Cancer 2014.
15. Kochl R., Hu X.W., Chan E.Y., Tooze S.A. Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic 2006, 7:129-145.
16. Liu H., He Z., Simon H.U. Targeting autophagy as a potential therapeutic approach for melanoma therapy. Semin Cancer Biol 2013, 23:352-360.
17. Yousefi S., Perozzo R., Schmid I., Ziemiecki A., Schaffner T., Scapozza L., et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006, 8:1124-1132.
18. Wirawan E., Vande Walle L., Kersse K., Cornelis S., Claerhout S., Vanoverberghe I., et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 2010, 1:e18.
19. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.
20. Li X., Fan Z. The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 2010, 70:5942-5952.
21. Thomson A.W., Turnquist H.R., Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 2009, 9:324-337.
22. Townsend K.N., Hughson L.R., Schlie K., Poon V.I., Westerback A., Lum J.J. Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity. Immunol Rev 2012, 249:176-194.
23. Kaper F., Dornhoefer N., Giaccia A.J. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions. Cancer Res 2006, 66:1561-1569.
24. Zhou X., Ikenoue T., Chen X., Li L., Inoki K., Guan K.L. Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy. Proc Natl Acad Sci U S A 2009, 106:8923-8928.
25. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008, 30:214-226.
26. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011, 13:132-141.
27. Lee J.W., Park S., Takahashi Y., Wang H.G. The association of AMPK with ULK1 regulates autophagy. PLoS ONE 2010, 5:e15394.
28. Sanli T., Rashid A., Liu C., Harding S., Bristow R.G., Cutz J.C., et al. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys 2010, 78:221-229.
29. Hoyer-Hansen M., Bastholm L., Szyniarowski P., Campanella M., Szabadkai G., Farkas T., et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell 2007, 25:193-205.
30. Sakaki K., Wu J., Kaufman R.J. Protein kinase Ctheta is required for autophagy in response to stress in the endoplasmic reticulum. J Biol Chem 2008, 283:15370-15380.
31. Samari H.R., Moller M.T., Holden L., Asmyhr T., Seglen P.O. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins. Biochem J 2005, 386:237-244.
32. Zhu L.Q., Zhen Y.F., Zhang Y., Guo Z.X., Dai J., Wang X.D. Salinomycin activates AMP-activated protein kinase-dependent autophagy in cultured osteoblastoma cells: a negative regulator against cell apoptosis. PLOS ONE 2013, 8:e84175.
33. Sini P., James D., Chresta C., Guichard S. Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells. Autophagy 2010, 6:553-554.
34. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
35. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007, 6:458-471.
36. Fan Q.W., Cheng C., Hackett C., Feldman M., Houseman B.T., Nicolaides T., et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 2010, 3:ra81.
37. Liu T.J., Koul D., LaFortune T., Tiao N., Shen R.J., Maira S.M., et al. NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Mol Cancer Ther 2009, 8:2204-2210.
38. Xu C.X., Zhao L., Yue P., Fang G., Tao H., Owonikoko T.K., et al. Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy. Cancer Biol Ther 2011, 12:549-555.
39. Zou C.Y., Smith K.D., Zhu Q.S., Liu J., McCutcheon I.E., Slopis J.M., et al. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther 2009, 8:1157-1168.
40. Cheng Y., Ren X., Zhang Y., Patel R., Sharma A., Wu H., et al. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 2011, 71:2654-2663.
41. Fu L., Kim Y.A., Wang X., Wu X., Yue P., Lonial S., et al. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res 2009, 69:8967-8976.
42. Tong Y., Liu Y.Y., You L.S., Qian W.B. Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Acta Pharmacol Sin 2012, 33:542-550.
43. Wei Y., Zou Z., Becker N., Anderson M., Sumpter R., Xiao G., et al. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 2013, 154:1269-1284.
44. Weihua Z., Tsan R., Huang W.C., Wu Q., Chiu C.H., Fidler I.J., et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 2008, 13:385-393.
45. Fung C., Chen X., Grandis J.R., Duvvuri U. EGFR tyrosine kinase inhibition induces autophagy in cancer cells. Cancer Biol Ther 2012, 13:1417-1424.
46. Kamenecka T., Habel J., Duckett D., Chen W., Ling Y.Y., Frackowiak B., et al. Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38. J Biol Chem 2009, 284:12853-12861.
47. Byun J.Y., Yoon C.H., An S., Park I.C., Kang C.M., Kim M.J., et al. The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras. Carcinogenesis 2009, 30:1880-1888.
48. Kim M.J., Woo S.J., Yoon C.H., Lee J.S., An S., Choi Y.H., et al. Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. J Biol Chem 2011, 286:12924-12932.
49. Park K.J., Lee S.H., Lee C.H., Jang J.Y., Chung J., Kwon M.H., et al. Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem Biophys Res Commun 2009, 382:726-729.
50. Jung K.H., Noh J.H., Kim J.K., Eun J.W., Bae H.J., Chang Y.G., et al. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer. Hepatology 2012, 56:644-657.
51. Kim A.D., Kang K.A., Kim H.S., Kim D.H., Choi Y.H., Lee S.J., et al. A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis 2013, 4:e750.
52. Li D.D., Wang L.L., Deng R., Tang J., Shen Y., Guo J.F., et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009, 28:886-898.
53. Elgendy M., Sheridan C., Brumatti G., Martin S.J. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 2011, 42:23-35.
54. Guo J.Y., Chen H.Y., Mathew R., Fan J., Strohecker A.M., Karsli-Uzunbas G., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011, 25:460-470.
55. Kalas W., Swiderek E., Rapak A., Kopij M., Rak J., Strzadala L. H-ras up-regulates expression of BNIP3. Anticancer Res 2011, 31:2869-2875.
56. Yang Z.J., Chee C.E., Huang S., Sinicrope F.A. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011, 10:1533-1541.
57. Cagnol S., Chambard J.C. ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence. FEBS J 2010, 277:2-21.
58. Maddodi N., Huang W., Havighurst T., Kim K., Longley B.J., Setaluri V. Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol 2010, 130:1657-1667.
59. Sivaprasad U., Basu A. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med 2008, 12:1265-1271.
60. Zhang Q., Si S., Schoen S., Chen J., Jin X.B., Wu G. Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells. J Exp Clin Cancer Res 2013, 32:99.
61. Furuta S., Hidaka E., Ogata A., Yokota S., Kamata T. Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 2004, 23:3898-3904.
62. Mancias J.D., Kimmelman A.C. Targeting autophagy addiction in cancer. Oncotarget 2011, 2:1302-1306.
63. Yang S., Wang X., Contino G., Liesa M., Sahin E., Ying H., et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011, 25:717-729.
64. Wang M., Kern A.M., Hulskotter M., Greninger P., Singh A., Pan Y., et al. EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation. Cancer Res 2014.
65. Chiacchiera F., Matrone A., Ferrari E., Ingravallo G., Lo Sasso G., Murzilli S., et al. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ 2009, 16:1203-1214.
66. Matrone A., Grossi V., Chiacchiera F., Fina E., Cappellari M., Caringella A.M., et al. p38alpha is required for ovarian cancer cell metabolism and survival. Int J Gynecol Cancer 2010, 20:203-211.
67. Comes F., Matrone A., Lastella P., Nico B., Susca F.C., Bagnulo R., et al. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ 2007, 14:693-702.
68. Moruno-Manchon J.F., Perez-Jimenez E., Knecht E. Glucose induces autophagy under starvation conditions by a p38 MAPK-dependent pathway. Biochem J 2013, 449:497-506.
69. Liu B., Cheng Y., Bian H.J., Bao J.K. Molecular mechanisms of Polygonatum cyrtonema lectin-induced apoptosis and autophagy in cancer cells. Autophagy 2009, 5:253-255.
70. Meijer T.W., Kaanders J.H., Span P.N., Bussink J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 2012, 18:5585-5594.
71. Emerling B.M., Weinberg F., Snyder C., Burgess Z., Mutlu G.M., Viollet B., et al. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med 2009, 46:1386-1391.
72. Mazure N.M., Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival. Curr Opin Cell Biol 2009, 22:177-180.
73. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouyssegur J., et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009, 29:2570-2581.
74. Horak P., Crawford A.R., Vadysirisack D.D., Nash Z.M., DeYoung M.P., Sgroi D., et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A 2010, 107:4675-4680.
75. DeYoung M.P., Horak P., Sofer A., Sgroi D., Ellisen L.W. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008, 22:239-251.
76. Agani F., Jiang B.H. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets 2013, 13:245-251.
77. Harada H., Itasaka S., Kizaka-Kondoh S., Shibuya K., Morinibu A., Shinomiya K., et al. The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. J Biol Chem 2009, 284:5332-5342.
78. Brugarolas J.B., Vazquez F., Reddy A., Sellers W.R., Kaelin W.G. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 2003, 4:147-158.
79. Eckerich C., Zapf S., Fillbrandt R., Loges S., Westphal M., Lamszus K. Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. Int J Cancer 2007, 121:276-283.
80. Koong A.C., Auger E.A., Chen E.Y., Giaccia A.J. The regulation of GRP78 and messenger RNA levels by hypoxia is modulated by protein kinase C activators and inhibitors. Radiat Res 1994, 138:S60-S63.
81. Bi M., Naczki C., Koritzinsky M., Fels D., Blais J., Hu N., et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005, 24:3470-3481.
82. Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
83. Ameri K., Lewis C.E., Raida M., Sowter H., Hai T., Harris A.L. Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells. Blood 2004, 103:1876-1882.
84. Koong A.C., Chen E.Y., Giaccia A.J. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 1994, 54:1425-1430.
85. Inoue D., Suzuki T., Mitsuishi Y., Miki Y., Suzuki S., Sugawara S., et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 2012, 103:760-766.
86. Novoa I., Zeng H., Harding H.P., Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 2001, 153:1011-1022.
87. B'Chir W., Maurin A.C., Carraro V., Averous J., Jousse C., Muranishi Y., et al. The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res 2013, 41:7683-7699.
88. Rouschop K.M., van den Beucken T., Dubois L., Niessen H., Bussink J., Savelkouls K., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 2010, 120:127-141.
89. Rzymski T., Milani M., Pike L., Buffa F., Mellor H.R., Winchester L., et al. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 2010, 29:4424-4435.
90. Kouroku Y., Fujita E., Tanida I., Ueno T., Isoai A., Kumagai H., et al. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 2007, 14:230-239.
91. Nagelkerke A., Bussink J., van der Kogel A.J., Sweep F.C., Span P.N. The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response. Radiother Oncol 2013, 108:415-421.
92. Mujcic H., Nagelkerke A., Rouschop K.M., Chung S., Chaudary N., Span P.N., et al. Hypoxic activation of the PERK/eIF2alpha arm of the unfolded protein response promotes metastasis through induction of LAMP3. Clin Cancer Res 2013, 19:6126-6137.
93. Nagelkerke A., Bussink J., Mujcic H., Wouters B.G., Lehmann S., Sweep F.C., et al. Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Res 2013, 15:R2.
94. Avivar-Valderas A., Salas E., Bobrovnikova-Marjon E., Diehl J.A., Nagi C., Debnath J., et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol 2011, 31:3616-3629.
95. Verfaillie T., Rubio N., Garg A.D., Bultynck G., Rizzuto R., Decuypere J.P., et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ 2012, 19:1880-1891.
96. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318:944-949.
97. Romero-Ramirez L., Cao H., Nelson D., Hammond E., Lee A.H., Yoshida H., et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res 2004, 64:5943-5947.
98. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006, 26:9220-9231.
99. Choi C.H., Jung Y.K., Oh S.H. Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signal-regulated mitogen-activated protein kinases and retards cell death by suppressing endoplasmic reticulum stress-mediated apoptosis. Mol Pharmacol 2010, 78:114-125.
100. Criollo A., Senovilla L., Authier H., Maiuri M.C., Morselli E., Vitale I., et al. The IKK complex contributes to the induction of autophagy. EMBO J 2010, 29:619-631.
101. Djavaheri-Mergny M., Amelotti M., Mathieu J., Besancon F., Bauvy C., Souquere S., et al. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J Biol Chem 2006, 281:30373-30382.
102. Ghosh S., Tergaonkar V., Rothlin C.V., Correa R.G., Bottero V., Bist P., et al. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival. Cancer Cell 2006, 10:215-226.
103. Nivon M., Richet E., Codogno P., Arrigo A.P., Kretz-Remy C. Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy 2009, 5:766-783.
104. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137:1062-1075.
105. Comb W.C., Cogswell P., Sitcheran R., Baldwin A.S. IKK-dependent, NF-kappaB-independent control of autophagic gene expression. Oncogene 2011, 30:1727-1732.
106. Dan H.C., Baldwin A.S. Differential involvement of IkappaB kinases alpha and beta in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt. J Immunol 2008, 180:7582-7589.
107. Chen N., Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 2011, 11:157-168.
108. Arico S., Petiot A., Bauvy C., Dubbelhuis P.F., Meijer A.J., Codogno P., et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 2001, 276:35243-35246.
109. Ueno T., Sato W., Horie Y., Komatsu M., Tanida I., Yoshida M., et al. Loss of Pten, a tumor suppressor, causes the strong inhibition of autophagy without affecting LC3 lipidation. Autophagy 2008, 4:692-700.
110. 2 mediated cell survival in SU11274-treated non-small-cell lung cancer A549 cells via c-Met-PI3K-Akt and c-Met-Grb2/SOS-Ras-p38 pathways. J Pharmacol Sci 2012, 119:150-159.
111. Liu Y., Yang Y., Ye Y.C., Shi Q.F., Chai K., Tashiro S., et al. Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cells. J Pharmacol Sci 2012, 118:423-432.
112. Kitajima Y., Ide T., Ohtsuka T., Miyazaki K. Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci 2008, 99:1341-1347.
113. Humbert M., Medova M., Aebersold D.M., Blaukat A., Bladt F., Fey M.F., et al. Protective autophagy is involved in resistance towards MET inhibitors in human gastric adenocarcinoma cells. Biochem Biophys Res Commun 2013, 431:264-269.
114. Liu Y., Liu J.H., Chai K., Tashiro S., Onodera S., Ikejima T. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells. J Pharm Pharmacol 2013, 65:1622-1642.
115. Tsuneoka M., Umata T., Kimura H., Koda Y., Nakajima M., Kosai K., et al. c-myc induces autophagy in rat 3Y1 fibroblast cells. Cell Struct Funct 2003, 28:195-204.
116. Nagy P., Varga A., Pircs K., Hegedus K., Juhasz G. Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogaster. PLoS Genet 2013, 9:e1003664.
117. Toh P.P., Luo S., Menzies F.M., Rasko T., Wanker E.E., Rubinsztein D.C. Myc inhibition impairs autophagosome formation. Hum Mol Genet 2013, 22:5237-5248.
118. Hart L.S., Cunningham J.T., Datta T., Dey S., Tameire F., Lehman S.L., et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest 2012, 122:4621-4634.
119. Dey S., Tameire F., Koumenis C. PERK-ing up autophagy during MYC-induced tumorigenesis. Autophagy 2013, 9:612-614.
120. Shen S., Niso-Santano M., Adjemian S., Takehara T., Malik S.A., Minoux H., et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell 2012, 48:667-680.
121. McCormick J., Suleman N., Scarabelli T.M., Knight R.A., Latchman D.S., Stephanou A. STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. J Cell Mol Med 2012, 16:386-393.
122. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
123. Gavilan E., Sanchez-Aguayo I., Daza P., Ruano D. GSK-3beta signaling determines autophagy activation in the breast tumor cell line MCF7 and inclusion formation in the non-tumor cell line MCF10A in response to proteasome inhibition. Cell Death Dis 2013, 4:e572.
124. Pal K., Cao Y., Gaisina I.N., Bhattacharya S., Dutta S.K., Wang E., et al. Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer. Mol Cancer Ther 2014, 13:285-296.
125. Yang J., Takahashi Y., Cheng E., Liu J., Terranova P.F., Zhao B., et al. GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J Cell Sci 2010, 123:861-870.
126. Zhou X., Zhou J., Li X., Guo C., Fang T., Chen Z. GSK-3beta inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury. Biochem Biophys Res Commun 2011, 411:271-275.
127. Petherick K.J., Williams A.C., Lane J.D., Ordonez-Moran P., Huelsken J., Collard T.J., et al. Autolysosomal beta-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J 2013, 32:1903-1916.
128. Chang H.W., Lee Y.S., Nam H.Y., Han M.W., Kim H.J., Moon S.Y., et al. Knockdown of beta-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal 2013, 25:839-847.
129. Choi J.D., Ryu M., Ae Park M., Jeong G., Lee J.S. FIP200 inhibits beta-catenin-mediated transcription by promoting APC-independent beta-catenin ubiquitination. Oncogene 2013, 32:2421-2432.
130. Gao C., Cao W., Bao L., Zuo W., Xie G., Cai T., et al. Autophagy negatively regulates Wnt signalling by promoting dishevelled degradation. Nat Cell Biol 2010, 12:781-790.
131. Zheng Z., Yang J., Zhao D., Gao D., Yan X., Yao Z., et al. Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells. FEBS J 2013, 280:4522-4530.
132. Ahn J.H., Lee M. Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2. Cancer Lett 2011, 310:188-197.
133. Simpkins F., Hevia-Paez P., Sun J., Ullmer W., Gilbert C.A., da Silva T., et al. Src inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo. Clin Cancer Res 2012, 18:5911-5923.
134. Milano V., Piao Y., LaFortune T., de Groot J. Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma. Mol Cancer Ther 2009, 8:394-406.
135. de Albuquerque-Xavier A.C., Bastos L.G., de Freitas J.C., Leve F., de Souza W.F., de Araujo W.M., et al. Blockade of irradiation-induced autophagosome formation impairs proliferation but does not enhance cell death in HCT-116 human colorectal carcinoma cells. Int J Oncol 2012, 40:1267-1276.
136. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
137. Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E., et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
138. Yue Z., Jin S., Yang C., Levine A.J., Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003, 100:15077-15082.
139. Takamura A., Komatsu M., Hara T., Sakamoto A., Kishi C., Waguri S., et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011, 25:795-800.